Markets
Three Dividend Giants for $10,000 as Tech Cools
As investors rotate out of technology, three dividend-growth stocks—AbbVie, Procter & Gamble, and Enterprise Products Partners—offer stability and attractive yields for a...
#pharmaceuticals 15 articles
Stocks
NervGen Pharma Prices $60 Million Public Offering
NervGen Pharma Corp. has priced a public offering of common shares and warrants, raising $60 million to advance its neuroreparative therapeutics.
Stocks
Ars Pharmaceuticals Expands $199 Access Program, Awaits CVS Caremark Decision
Ars Pharmaceuticals is expanding its $199 neffy retail access program while awaiting a crucial decision from CVS Caremark, aiming to boost affordability...
Markets
Three Healthcare Stocks Offering Retirees Up To 6.5% Yield
Retirees seeking income can find compelling opportunities in the healthcare sector. Three dividend-paying stocks—Pfizer, Medtronic, and Omega Healthcare—offer yields up to 6.5%...
Stocks
Recursion Projects 2028 Runway, Holds 2026 Expenses Below $390M
Recursion Pharmaceuticals projects its operational runway into early 2028 while committing to keep 2026 cash operating expenses under $390 million, driven by...
Markets
Pfizer Stock: Is Its ‘Dead Money’ Tag Misleading?
Pfizer shares have fallen over 50% from their 2021 high, leading many to label it "dead money." However, a closer look reveals...
Stocks
Quantum BioPharma Taps Senergy, King Tide for Investor Outreach
Quantum BioPharma Ltd. has engaged Senergy Communications Capital Inc. and King Tide Media LLC for a one-month contract to bolster investor awareness...
Markets
Eli Lilly’s Diversification Offers Stronger Investment Case
Beyond its weight-loss drug success, Eli Lilly's robust pipeline across oncology, immunology, and neuroscience presents a compelling investment thesis.
Stocks
Eli Lilly Nears $2B-Plus Kelonia Deal for Cancer Pipeline
Eli Lilly is in advanced talks to acquire Kelonia Therapeutics for over $2 billion, aiming to expand its cancer pipeline, The Wall...